M van Engeland - JoVE Visualize

Showing results (1-10 of 23) with videos related to

Pageof 3

Sort By:

Cytometry|June 1, 1996

A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in cultureM van Engeland, F C Ramaekers, B Schutte, et al.

Cytometry|February 5, 1998

Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposureM van Engeland, L J Nieland, F C Ramaekers, et al.

Experimental Cell Research|September 23, 1997

Plasma membrane alterations and cytoskeletal changes in apoptosisM van Engeland, H J Kuijpers, F C Ramaekers, et al.

Experimental Cell Research|November 5, 1997

The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kineticsB Schutte, L Nieland, M van Engeland, et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 10, 2002

Alendronate in the prevention of bone loss after a fracture of the lower legE van der Poest Clement, M van Engeland, H Adèr, et al.

European Journal of Cell Biology|July 1, 1996

Subcellular localization of proteasomes in apoptotic lung tumor cells and persistence as compared to intermediate filamentsB M Machiels, M E Henfling, B Schutte, et al.

The Journal of Pathology|November 11, 2006

Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implantsN L Sieben, G M J M Roemen, J Oosting, et al.

Gynecologic Oncology|August 7, 2004

Defective mismatch repair and the development of recurrent endometrial carcinomaJ M A Pijnenborg, G C Dam-de Veen, J de Haan, et al.

Biochimica Et Biophysica Acta|December 3, 2014

Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectivesS C Joosten, L Hamming, P M Soetekouw, et al.

British Journal of Cancer|August 30, 2008

Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosisA H G Cleven, B G Wouters, B Schutte, et al.

Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:

Pageof 3

Cytometry|June 1, 1996

A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in cultureM van Engeland, F C Ramaekers, B Schutte, et al.

Cytometry|February 5, 1998

Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposureM van Engeland, L J Nieland, F C Ramaekers, et al.

Experimental Cell Research|September 23, 1997

Plasma membrane alterations and cytoskeletal changes in apoptosisM van Engeland, H J Kuijpers, F C Ramaekers, et al.

Experimental Cell Research|November 5, 1997

The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kineticsB Schutte, L Nieland, M van Engeland, et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 10, 2002

Alendronate in the prevention of bone loss after a fracture of the lower legE van der Poest Clement, M van Engeland, H Adèr, et al.

European Journal of Cell Biology|July 1, 1996

Subcellular localization of proteasomes in apoptotic lung tumor cells and persistence as compared to intermediate filamentsB M Machiels, M E Henfling, B Schutte, et al.

The Journal of Pathology|November 11, 2006

Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implantsN L Sieben, G M J M Roemen, J Oosting, et al.

Gynecologic Oncology|August 7, 2004

Defective mismatch repair and the development of recurrent endometrial carcinomaJ M A Pijnenborg, G C Dam-de Veen, J de Haan, et al.

Biochimica Et Biophysica Acta|December 3, 2014

Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectivesS C Joosten, L Hamming, P M Soetekouw, et al.

British Journal of Cancer|August 30, 2008

Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosisA H G Cleven, B G Wouters, B Schutte, et al.

Pageof 3